This issue (November 17–19) shows the laser industry “extending at both ends”: overseas high-energy laser weapons completed the most combat-realistic kill verification to date; a domestic optical chip unicorn started its IPO sprint; and medical lasers saw new progress in the hands of a leading equipment maker.
1. 300 kW laser weapon completes a “full kill chain” for the first time, downing a cruise missile target
On November 18, according to Defence-Blog, Lockheed Martin announced that its high-energy laser weapon shot down a cruise missile target for the first time. Codenamed “Valkyrie” and formally named Indirect Fire Protection Capability–High Energy Laser (IFPC-HEL), the system outputs 300 kW—a relatively high level among the laser weapons tested by the US military. The company’s program director for lasers and sensor systems stressed that this was an “engagement with full kill-chain integration”—detection, tracking, lock-on, firing and damage assessment all ran through—and it was completed without tracking enhancement (the target carried no beacon or reflector aids), with a very short engagement time, making its technical substance markedly higher than previous segment-by-segment verification tests.
Intriguing is the contrast between the technical breakthrough and the fielding decision: according to a Congressional Research Service report, the US Army no longer plans to move the system into active service. The technical route, however, has not been interrupted—in its FY2027 budget request the Pentagon proposed applying the project’s experience to a new “Joint Laser Weapon System” jointly advanced by the Army and the Navy. Earlier, the system was demonstrated to defense leadership at White Sands Missile Range in June, and in July Lockheed and nLight won contracts totaling USD 86 million with a ceiling of USD 847 million, aimed squarely at a laser weapon able to down cruise missiles.
Industry impact: The core challenge of 300 kW-class laser air defense has shifted from “whether it can burn through the target” to engineering aspects such as power supply, heat dissipation, beam stability and atmospheric adaptation. Laser interception with extremely low cost per shot and no ammunition inventory limit is highly attractive for drone swarm defense, but the path from demonstration to fielding remains long, and global military high-energy laser demand stays at a high level.
2. Vertilite starts STAR Market IPO tutoring: over 900 million VCSELs shipped cumulatively
The CSRC’s IPO tutoring disclosure system shows that Jiangsu Vertilite Semiconductor Technology Co., Ltd. (纵慧芯光) has filed for tutoring with the Jiangsu Securities Regulatory Bureau, with Guotai Haitong Securities as tutor, formally sprinting for the STAR Market. Founded in 2015 by a Stanford PhD team, this VCSEL (vertical-cavity surface-emitting laser) chip company had shipped over 900 million chips cumulatively by September 2026, and in 2019 became the first domestic company to achieve VCSEL volume production.
Its shareholder list is all-star: industrial capital including Huawei’s Hubble Investment, the Xiaomi Yangtze River Industrial Fund, BYD, DJI, Hesai and RoboSense have all taken positions. On the product side, its anti-reflection VCSELs have been supplied to RoboSense, Hesai and Waymo, supporting LiDAR with annual vehicle installations exceeding 1 million units and a market share of over 60% in domestic EV LiDAR light sources; in 2024 the team published its six-junction AR-VCSEL result in Nature Communications, halving beam divergence and roughly tripling brightness.
Its capital moves are compact: it completed the joint-stock reform in July 2026, and in August signed in Changzhou a high-end optical communication chip and device R&D and manufacturing base with total investment of about CNY 5 billion, focusing on building InP high-end laser chip production lines and extending into the data center optical interconnect track.
Industry impact: VCSELs are making a triple jump from “phone 3D sensing” to “automotive LiDAR” to “AI data center optical interconnect”, and Vertilite’s IPO process also highlights an audit focus—the fairness of related-party transactions where major customers double as shareholders. Capitalization of domestic optical chip companies is accelerating.
3. Hymson’s hair-growth laser device enters clinical trials
On November 18, Hymson disclosed on the SSE e-Interaction platform that its medical laser R&D is advancing as planned, with the hair-growth laser device already in the clinical trial stage; it still needs to complete medical device registration filing and review approval before launch. The company has partnered with dermatology departments of several leading domestic hospitals to advance research on laser hair-growth mechanisms. In the first three quarters of 2026, Hymson posted revenue of CNY 4.904 billion, up 81.38% YoY, and net profit attributable to shareholders of CNY 133 million, turning from loss to profit.
Industry impact: Laser equipment makers for lithium batteries and consumer electronics are reusing their laser capabilities in the healthcare field; facing the huge hair-loss population and the non-invasive treatment market, medical lasers could become the second growth curve for equipment makers, though medical device registration and approval cycles remain an uncertainty.
4. Industry briefs
· Han’s Laser completes its share buyback: from November 3 to 17 it repurchased a cumulative 5,929,600 shares (0.58% of total share capital) through centralized bidding at CNY 46.55–54.10 per share, paying a total of CNY 299.97 million; the buyback plan has been fully implemented.
· Precilasers granted an invention patent: on November 17, “A single-frequency laser-pumped thulium-doped distributed feedback fiber laser” was granted; by pumping with a single-frequency laser it avoids inter-mode beat frequencies, improving single-frequency laser wavelength stability, narrowing the linewidth and reducing intensity and frequency noise. The company listed on the STAR Market on August 18 this year and posted Q3 revenue of CNY 384 million and net profit of CNY 112 million.
· Xuanxiang Technology (璇相科技) completes a new financing round: investors include HuaGai Capital (华盖资本), FreeS Fund, GGV Capital, ZhenFund, Shanghai S&T Innovation Fund (上海科创基金) and AgiBot Robotics (智元机器人). The company focuses on metasurface atom-tweezer chips and has achieved mass production of metasurface chips for million-atom optical tweezer arrays, serving neutral-atom quantum computing and quantum precision measurement.
Industry Observations
This issue presents a “two-end extension” pattern: at one end, military high-energy lasers are edging closer to combat use—the 300 kW-class “full kill chain” verification marks laser air defense moving from technical demonstration to engineering landing, though the Army’s cautious pause on fielding also shows that bottlenecks in power, power supply and atmospheric adaptation are not yet fully broken; at the other end, capital enthusiasm for optical chips spreads from M&A to IPO—Vertilite sprinting for the STAR Market with the triple story of “consumer electronics + automotive + AI optical interconnect” confirms the strategic value of laser chips such as VCSELs in the AI computing era. With the CPO concept remaining active in secondary markets, the optical interconnect thread stays hot. For buyers, the selectable range of domestic laser chips and light sources keeps growing; tracking their capacity and automotive/data center certification progress is the key to seizing cost-performance windows.
Disclaimer: This article is compiled from public reports including Defence-Blog, National Business Daily, 36Kr, Shanghai Securities News, Stockstar and OFweek Laser Network, for industry reference only and not as investment advice.



Leave a Reply